Veterinary Medicines

Vanguard CPV-Lepto suspension injectable pour chiens

Authorised
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
Download as PDF

Product identification

Medicine name:
Vanguard CPV-Lepto suspension injectable pour chiens
Vanguard CPV-Lepto Injektionssuspension
Active substance:
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain NL-35-D, Live
    10000000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
    40.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    40.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AL04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Vanguard CPV-Lepto 1 dose Vial Suspension for injection
  • Vanguard CPV-Lepto 10 1 dose Vial Suspension for injection
  • Vanguard CPV-Lepto 100 1 dose Vial Suspension for injection
  • Vanguard CPV-Lepto 25 1 dose Vial Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 087/93/11/0350
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/01/2024
Download